Xylem Inc. (LON:0M29)
London
· Delayed Price · Currency is GBP · Price in USD 129.71
-0.80 (-0.61%)
At close: Feb 19, 2025
Xylem Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 8,562 | 7,364 | 5,522 | 5,195 | 4,876 | Upgrade
|
| Revenue Growth (YoY) | 16.27% | 33.36% | 6.29% | 6.54% | -7.11% | Upgrade
|
| Cost of Revenue | 5,350 | 4,647 | 3,438 | 3,220 | 3,046 | Upgrade
|
| Gross Profit | 3,212 | 2,717 | 2,084 | 1,975 | 1,830 | Upgrade
|
| Selling, General & Admin | 1,911 | 1,633 | 1,237 | 1,193 | 1,158 | Upgrade
|
| Research & Development | 230 | 232 | 206 | 204 | 187 | Upgrade
|
| Operating Expenses | 2,141 | 1,865 | 1,443 | 1,397 | 1,345 | Upgrade
|
| Operating Income | 1,071 | 852 | 641 | 578 | 485 | Upgrade
|
| Interest Expense | -44 | -49 | -50 | -76 | -77 | Upgrade
|
| Interest & Investment Income | - | 28 | 16 | 7 | 7 | Upgrade
|
| Earnings From Equity Investments | - | - | - | 9 | 2 | Upgrade
|
| Other Non Operating Income (Expenses) | 16 | 7 | 1 | -2 | 1 | Upgrade
|
| EBT Excluding Unusual Items | 1,043 | 838 | 608 | 516 | 418 | Upgrade
|
| Merger & Restructuring Charges | -55 | -198 | -15 | -6 | -54 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -58 | Upgrade
|
| Gain (Loss) on Sale of Investments | 152 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -46 | -1 | 1 | 2 | - | Upgrade
|
| Asset Writedown | -7 | -4 | -14 | -1 | -21 | Upgrade
|
| Other Unusual Items | - | - | -140 | - | - | Upgrade
|
| Pretax Income | 1,087 | 635 | 440 | 511 | 285 | Upgrade
|
| Income Tax Expense | 197 | 26 | 85 | 84 | 31 | Upgrade
|
| Earnings From Continuing Operations | 890 | 609 | 355 | 427 | 254 | Upgrade
|
| Net Income | 890 | 609 | 355 | 427 | 254 | Upgrade
|
| Net Income to Common | 890 | 609 | 355 | 427 | 254 | Upgrade
|
| Net Income Growth | 46.14% | 71.55% | -16.86% | 68.11% | -36.66% | Upgrade
|
| Shares Outstanding (Basic) | 243 | 217 | 180 | 180 | 180 | Upgrade
|
| Shares Outstanding (Diluted) | 244 | 218 | 181 | 182 | 181 | Upgrade
|
| Shares Change (YoY) | 11.61% | 20.56% | -0.30% | 0.24% | -0.05% | Upgrade
|
| EPS (Basic) | 3.67 | 2.81 | 1.97 | 2.37 | 1.41 | Upgrade
|
| EPS (Diluted) | 3.65 | 2.79 | 1.96 | 2.35 | 1.40 | Upgrade
|
| EPS Growth | 30.82% | 42.35% | -16.60% | 67.86% | -36.65% | Upgrade
|
| Free Cash Flow | 942 | 566 | 388 | 330 | 641 | Upgrade
|
| Free Cash Flow Per Share | 3.87 | 2.59 | 2.14 | 1.82 | 3.54 | Upgrade
|
| Dividend Per Share | 1.440 | 1.320 | 1.200 | 1.120 | 1.040 | Upgrade
|
| Dividend Growth | 9.09% | 10.00% | 7.14% | 7.69% | 8.33% | Upgrade
|
| Gross Margin | 37.51% | 36.90% | 37.74% | 38.02% | 37.53% | Upgrade
|
| Operating Margin | 12.51% | 11.57% | 11.61% | 11.13% | 9.95% | Upgrade
|
| Profit Margin | 10.39% | 8.27% | 6.43% | 8.22% | 5.21% | Upgrade
|
| Free Cash Flow Margin | 11.00% | 7.69% | 7.03% | 6.35% | 13.15% | Upgrade
|
| EBITDA | 1,633 | 1,288 | 880 | 824 | 736 | Upgrade
|
| EBITDA Margin | 19.07% | 17.49% | 15.94% | 15.86% | 15.09% | Upgrade
|
| D&A For EBITDA | 562 | 436 | 239 | 246 | 251 | Upgrade
|
| EBIT | 1,071 | 852 | 641 | 578 | 485 | Upgrade
|
| EBIT Margin | 12.51% | 11.57% | 11.61% | 11.13% | 9.95% | Upgrade
|
| Effective Tax Rate | 18.12% | 4.09% | 19.32% | 16.44% | 10.88% | Upgrade
|
| Revenue as Reported | 8,562 | 7,364 | 5,522 | 5,195 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.